Medical device recalls Moderate risk

Beckman Coulter Inc recalls Triglycerides Reagent (TG 2 x 300), REF: 445850, For In Vitro Diagnostic Use, Rx Only, UDI: 15099590233228

Recall date
August 15, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1423-2020
FDA classification
Class II
Brand / firm
Beckman Coulter Inc
Sold / distributed
Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine,Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico,…

Why it was recalled

It has been determined that N-acetyl p benzoquinone imine (NAPQI), a metabolite of acetaminophen (paracetamol), may cause negative interference for assays if present in high quantities in serum due to acetaminophen overdoese. This could result in a delay in diagnosis and treatment.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Triglycerides Reagent (TG 2 x 300), REF: 445850, For In Vitro Diagnostic Use, Rx Only, UDI: 15099590233228

Get recall alerts

Free email alert whenever Beckman Coulter Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Beckman Coulter Inc